| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |